Seasonal affective disorder (SAD) is a type of depression linked to seasonal changes, primarily occurring during fall and winter. Its applications involve diagnosing and treating individuals experiencing mood disturbances during specific seasons. Key features include recurring patterns of depressive symptoms, such as low energy, irritability, and oversleeping. SAD's primary use is to help healthcare professionals identify and manage this condition, enabling the implementation of appropriate interventions such as light therapy, counseling, and medication to alleviate symptoms and improve patients' well-being during the affected seasons.
According to Data Bridge Market Research, the Global Seasonal Affective Disorder Market accounted for USD 747.63 million in 2022 and is expected to reach USD 869.10 million by 2030. The market is expected to grow with a CAGR of 5.25% in the forecast period of 2023 to 2030.
“Increasing prevalence of this condition boosts the market’s growth”
The seasonal affective disorder (SAD) market experiences growth due to the increasing prevalence of this condition. Seasonal affective disorder is a type of depression that occurs during specific seasons, most commonly during the fall and winter months. As awareness of SAD rises and its impact on mental health becomes more recognized, more individuals seek diagnosis and treatment for the disorder. This growing demand for effective therapies and interventions drives pharmaceutical companies to invest in research and development, leading to the expansion of the SAD market.
What restraints the growth of the global seasonal affective disorder market?
“High cost of treatments and therapies restraints the market’s growth”
The growth of the seasonal affective disorder (SAD) market is limited by the high cost of treatments and therapies. Many SAD treatments, such as light therapy devices and certain medications, can be expensive for patients, especially those without adequate insurance coverage. The high cost of these interventions may deter some individuals from seeking or continuing treatment, impacting the market's growth potential. Efforts to develop more affordable treatment options and improve insurance coverage for SAD therapies can help address this restraint and facilitate market expansion.
Segmentation: Global Seasonal Affective Disorder Market
The global seasonal affective disorder market is segmented on the basis of type, diagnosis, and treatments, end-use.
- On the basis of type, the global seasonal affective disorder market is segmented into fall and winter SAD, spring and summer SAD, and others.
- On the basis of diagnosis, the global seasonal affective disorder market is segmented into physical exam, lab tests, psychological evaluation, and others.
- On the basis of treatments, the global seasonal affective disorder market is segmented into light therapy, medications, psychotherapy, counselling, and others.
- On the basis of end use, the global seasonal affective disorder market is segmented into hospitals, clinics, research institutes, and others.
Regional Insights: North America is expected to dominate the Global Seasonal Affective Disorder Market
North America is expected to dominate the seasonal affective disorder market due to the region's well-established healthcare facilities, significant market presence of major players, rising cases of seasonal affective disorder, and growing research activities contribute to its prominence in the market, making it a key hub for addressing and treating seasonal affective disorder.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 because of including government initiatives promoting awareness, the rise in medical tourism, growing research activities, the presence of untapped markets, a large population pool, and the increasing demand for quality healthcare services.
To know more about the study visit, https://www.databridgemarketresearch.com/reports/global-seasonal-affective-disorder-market
Recent Developments
- In February 2022, Granules India has obtained approval from the US Food and Drug Administration (FDA) to market Bupropion Hydrochloride extended-release tablets in the United States. These tablets are intended for the treatment of major depressive disorder and seasonal affective disorder.
- In June 2021, Alkermes plc's new drug, Lybalvi, has received approval from the US Food and Drug Administration (FDA) for treating schizophrenia and bipolar disorder. Lybalvi is a combination of the active ingredient found in Eli Lilly's Zyprexa and a newer chemical called samidorfan, forming a promising treatment option for these mental health conditions.
The Prominent Key Players Operating in the Global Seasonal Affective Disorder Market Include:
- Pfizer Inc. (U.S.)
- Lily (U.S.)
- GlaxoSmithKline (U.K.)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Bausch Health Companies Inc. (Canada)
- Viatris Inc. (U.S.)
- Johnson & Johnson (U.S.)
- Novartis AG (Switzerland)
- Sanofi (France)
- Koninklije Philips N.V. (Netherlands)
- Beurer GmbH (Germany)
- Lucimed (Belgium)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Bayer AG (Germany)
- AbbVie Inc. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Janssen Pharmaceuticals, Inc. (Belgium)
- Carex (U.S.)
- The SunBox Company (U.S.)
- Henry Schein, Inc. (U.S.)
Above are the key players covered in the report, to know about more and exhaustive list of global seasonal affective disorder market companies contact, https://www.databridgemarketresearch.com/contact
Research Methodology: Global Seasonal Affective Disorder Market
Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs Regional and Vendor Share Analysis. Please request analyst call in case of further inquiry.
